| Submission to first decision
(The average time from manuscript submission to desk rejection, direct rejection/acceptance or assignment to the first editor) Note: For manuscripts that fully comply with the journal template. However, this timeframe does not apply to manuscripts with formatting or guideline deficiencies. If a manuscript is returned to the authors for corrections, the administrative review process will restart from the re-submission date. |
3 weeks |
|---|---|
| Submission to decision after review (For papers that are sent to review, the average time from submission to receipt of first editor decision) | 6 weeks |
| Submission to final decision (The average time from manuscript submission to the final editorial decision) | 16 weeks |
| Submission to publication (The average time from acceptance to publication. Manuscript published in early view are also included in this calculation) | 24 weeks |
ACTA Pharmaceutica Sciencia
2011 , Vol 53 , Num 2
THERMOTRIGGERED INTRANASAL MICROEMULSIONS FOR NOSE TO BRAIN TARGETING OF RIZATRIPTAN
C.U. Shah College of Pharmacy, S.N.D.T Women’s University, Juhu, Santacruz (W), Mumbai, Maharashtra, India
Viewed :
20043
-
Downloaded :
83
Thermotriggered mucoadhesive (TTM) microemulsions were developed for nose to brain targeting of antimigraine drug, rizatriptan benzoate (RB). Intranasal TTM microemulsions were developed by spontaneous emulsification technique. Thermosensitive polymers like Pluronic F127 and Pluronic F68 were tried out to modulate the gelation of microemulsion formulations at physiological temperature after intranasal administration. Various mucoadhesive polymers were tried out in optimized thermo-triggered microemulsion formulations. The mucoadhesion force in terms of detachment stress determined using sheep nasal mucosa was higher with 0.05% w/v of Carbopol 980. TTM intranasal microemulsion was optimized based on permeability parameters such as steady-state flux, permeability coefficient and enhancement ratio. After a single dose administration (4mg/kg), the plasma concentration peaked at 15 min and the absolute bioavailability was about 94.84%. The uptake of RB in the brain from the nasal route was three folds, compared with intravenous (i.v.) injection. The ratios of AUC in whole brain tissue to that in plasma obtained after nasal administration were significantly higher than those after i.v. administration. These results suggest that TTM microemulsions have potential for nose to brain targeting of rizatriptan benzoate.
Keywords :
MICROEMULSION, MUCOADHESION, RIZATRIPTAN, PLURONICS, BRAIN TARGETING